This work is licensed under the Creative Commons Attribution 4.0 International License.
Guidance for Management of Pregnant Women in COVID-19 Pandemic. Mumbai, India: ICMR - National Institute for Research in Reproductive Health, 2020 Apr 12. Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women in_COVID19_Pandemic_12042020.pdfGuidance for Management of Pregnant Women in COVID-19 PandemicMumbai, IndiaICMR - National Institute for Research in Reproductive Health2020Apr12Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women in_COVID19_Pandemic_12042020.pdfSearch in Google Scholar
World Health Organization. Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period. Updated 15 March 2022. Q&A. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-pregnancy-and-childbirthWorld Health OrganizationCoronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal periodUpdated 15 March 2022. Q&A. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-pregnancy-and-childbirthSearch in Google Scholar
Kucirka LM, Norton A, Sheffield JS. Severity of COVID-19 in pregnancy: A review of current evidence. Am J Reprod Immunol. 2020;84(5):e13332. doi: 10.1111/aji.13332KucirkaLMNortonASheffieldJSSeverity of COVID-19 in pregnancy: A review of current evidenceAm J Reprod Immunol2020845e1333210.1111/aji.13332Open DOISearch in Google Scholar
Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–7. doi: 10.1016/j.ajog.2003.11.019WongSFChowKMLeungTNNgWFNgTKShekCCPregnancy and perinatal outcomes of women with severe acute respiratory syndromeAm J Obstet Gynecol20041911292710.1016/j.ajog.2003.11.019Open DOISearch in Google Scholar
Azinheira Nobrega Cruz N, Stoll D, Casarini DE, Bertagnolli M. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility. Clin Sci (Lond). 2021;135(15):1805–24. doi: 10.1042/CS20210284Azinheira Nobrega CruzNStollDCasariniDEBertagnolliMRole of ACE2 in pregnancy and potential implications for COVID-19 susceptibilityClin Sci (Lond)20211351518052410.1042/CS20210284Open DOISearch in Google Scholar
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–80.e8. doi: 10.1016/j.cell.2020.02.052HoffmannMKleine-WeberHSchroederSKrügerNHerrlerTErichsenSSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell2020181227180.e810.1016/j.cell.2020.02.052Open DOISearch in Google Scholar
Valdés G, Neves LA, Anton L, Corthorn J, Chacón C, Germain AM, et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006;27(2–3):200–7. doi: 10.1016/j.placenta.2005.02.015ValdésGNevesLAAntonLCorthornJChacónCGermainAMDistribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnanciesPlacenta2006272–3200710.1016/j.placenta.2005.02.015Open DOISearch in Google Scholar
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al.; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320; Update in: BMJ. 2022 May 30;377:o1205AlloteyJStallingsEBonetMYapMChatterjeeSKewTfor PregCOV-19 Living Systematic Review ConsortiumClinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ2020Sep1370m332010.1136/bmj.m3320Update in: BMJ. 2022 May 30;377:o1205Open DOISearch in Google Scholar
Centre for Disease Control and Prevention. COVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. 2021. Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html or CDC Centre for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Last updated July 20, 2022. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.htmlCentre for Disease Control and PreventionCOVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States2021Available from: https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html or CDC Centre for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Last updated July 20, 2022. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.htmlSearch in Google Scholar
Januszewski M, Ziuzia-Januszewska L, Jakimiuk AA, Wierzba W, Gluszko A, Zytynska-Daniluk J, et al. Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study. Int J Environ Res Public Health. 2021;18(22):12011. doi: 10.3390/ijerph182212011JanuszewskiMZiuzia-JanuszewskaLJakimiukAAWierzbaWGluszkoAZytynska-DanilukJIs the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative StudyInt J Environ Res Public Health202118221201110.3390/ijerph182212011Open DOISearch in Google Scholar
Balachandren N, Davies MC, Hall JA, Stephenson JM, David AL, Barrett G, et al. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Hum Reprod. 2022;37(6):1126–33. doi: 10.1093/humrep/deac062BalachandrenNDaviesMCHallJAStephensonJMDavidALBarrettGSARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemicHum Reprod202237611263310.1093/humrep/deac062Open DOISearch in Google Scholar
Sivanandan S, Chawla D, Kumar P; National Neonatology Forum of India (NNF), Federation of Obstetric and Gynaecological Societies of India (FOGSI), and Indian Academy of Pediatrics (IAP). Update to Perinatal-Neonatal Management of COVID-19 Guidelines. Indian Pediatr. 2022;59(1):63–6. doi: 10.1007/s13312-022-2423-7SivanandanSChawlaDKumarPNational Neonatology Forum of India (NNF), Federation of Obstetric and Gynaecological Societies of India (FOGSI), and Indian Academy of Pediatrics (IAP)Update to Perinatal-Neonatal Management of COVID-19 GuidelinesIndian Pediatr202259163610.1007/s13312-022-2423-7Open DOISearch in Google Scholar
Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY, et al.; CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med. 2021;385(16):1533–5. doi: 10.1056/NEJMc2113891ZaucheLHWallaceBSmootsANOlsonCKOduyeboTKimSYCDC v-safe Covid-19 Pregnancy Registry TeamReceipt of mRNA Covid-19 Vaccines and Risk of Spontaneous AbortionN Engl J Med2021385161533510.1056/NEJMc2113891Open DOISearch in Google Scholar
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al.; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021 Jun 17;384(24):2273–82. doi: 10.1056/NEJMoa2104983. Erratum in: N Engl J Med. 2021 Oct 14;385(16):1536ShimabukuroTTKimSYMyersTRMoroPLOduyeboTPanagiotakopoulosLCDC v-safe COVID-19 Pregnancy Registry TeamPreliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant PersonsN Engl J Med2021Jun173842422738210.1056/NEJMoa2104983Erratum in: N Engl J Med. 2021 Oct 14;385(16):1536Open DOISearch in Google Scholar
World Health Organization. Coronavirus disease (COVID-19): Vaccines. Q&A. Last updated 17 May 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccinesWorld Health OrganizationCoronavirus disease (COVID-19): Vaccines. Q&ALast updated 17 May 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccinesSearch in Google Scholar
Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG. 2022;129(2):248–55. doi: 10.1111/1471-0528.16941RottenstreichMSelaHYRotemRKadishEWiener-WellYGrisaru-GranovskySCovid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort studyBJOG202212922485510.1111/1471-0528.16941Open DOISearch in Google Scholar
Peretz-Machluf R, Hirsh-Yechezkel G, Zaslavsky-Paltiel I, Farhi A, Avisar N, Lerner-Geva L, et al. Obstetric and Neonatal Outcomes following COVID-19 Vaccination in Pregnancy. J Clin Med. 2022;11(9):2540. doi: 10.3390/jcm11092540Peretz-MachlufRHirsh-YechezkelGZaslavsky-PaltielIFarhiAAvisarNLerner-GevaLObstetric and Neonatal Outcomes following COVID-19 Vaccination in PregnancyJ Clin Med2022119254010.3390/jcm11092540Open DOISearch in Google Scholar
Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. 2020 Aug;25:100446. doi: 10.1016/j.eclinm.2020.100446KhalilAKalafatEBenliogluCO’BrienPMorrisEDraycottTSARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomesEClinicalMedicine2020Aug2510044610.1016/j.eclinm.2020.100446Open DOISearch in Google Scholar
Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–7. doi: 10.15585/mmwr.mm6944e3ZambranoLDEllingtonSStridPGalangRROduyeboTTongVTCDC COVID-19 Response Pregnancy and Infant Linked Outcomes TeamUpdate: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–October 3, 2020MMWR Morb Mortal Wkly Rep202069441641710.15585/mmwr.mm6944e3Open DOISearch in Google Scholar
Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548. doi: 10.1503/cmaj.202604WeiSQBilodeau-BertrandMLiuSAugerNThe impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysisCMAJ202119316E540E54810.1503/cmaj.202604Open DOISearch in Google Scholar
Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27(10):1693–5. doi: 10.1038/s41591-021-01490-8DaganNBardaNBiron-ShentalTMakov-AssifMKeyCKohaneISEffectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancyNat Med202127101693510.1038/s41591-021-01490-8Open DOISearch in Google Scholar
Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. 2021;326(8):728–35. doi: 10.1001/jama.2021.11035GoldshteinINevoDSteinbergDMRotemRSGorfineMChodickGAssociation Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant WomenJAMA202132687283510.1001/jama.2021.11035Open DOISearch in Google Scholar
Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225(3):303.e1–303.e17. doi: 10.1016/j.ajog.2021.03.023GrayKJBordtEAAtyeoCDerisoEAkinwunmiBYoungNCoronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort studyAm J Obstet Gynecol20212253303.e1303.e1710.1016/j.ajog.2021.03.023Open DOISearch in Google Scholar
Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, et al. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol. 2022;226(2):236.e1–236.e14. doi: 10.1016/j.ajog.2021.08.007BlakewayHPrasadSKalafatEHeathPTLadhaniSNLe DoareKCOVID-19 vaccination during pregnancy: coverage and safetyAm J Obstet Gynecol20222262236.e1236.e1410.1016/j.ajog.2021.08.007Open DOISearch in Google Scholar
Peepal P, Rath TS, Nayak S, Pendyala S. Maternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical study. J Mother Child. 2021;25(2):77–85. doi: 10.34763/jmotherandchild.20212502.d-21-00021PeepalPRathTSNayakSPendyalaSMaternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical studyJ Mother Child2021252778510.34763/jmotherandchild.20212502.d-21-00021Open DOISearch in Google Scholar
Karasek D, Baer RJ, McLemore MR, Bell AJ, Blebu BE, Casey JA, et al. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. Lancet Reg Health Am. 2021 Oct;2:100027. doi: 10.1016/j.lana.2021.100027KarasekDBaerRJMcLemoreMRBellAJBlebuBECaseyJAThe association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in CaliforniaLancet Reg Health Am2021Oct210002710.1016/j.lana.2021.100027Open DOISearch in Google Scholar
Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, et al. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(1):26–30. doi: 10.15585/mmwr.mm7101e1LipkindHSVazquez-BenitezGDeSilvaMVescoKKAckerman-BanksCZhuJReceipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021MMWR Morb Mortal Wkly Rep2022711263010.15585/mmwr.mm7101e1Open DOISearch in Google Scholar
Dick A, Rosenbloom JI, Gutman-Ido E, Lessans N, Cahen-Peretz A, Chill HH. Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study. BMC Pregnancy Childbirth. 2022;22(1):166. doi: 10.1186/s12884-022-04505-5DickARosenbloomJIGutman-IdoELessansNCahen-PeretzAChillHHSafety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort studyBMC Pregnancy Childbirth202222116610.1186/s12884-022-04505-5Open DOISearch in Google Scholar
Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. N Engl J Med. 2021;385(21):2008–2010. doi: 10.1056/NEJMc2114466MagnusMCGjessingHKEideHNWilcoxAJFellDBHåbergSECovid-19 Vaccination during Pregnancy and First-Trimester MiscarriageN Engl J Med2021385212008201010.1056/NEJMc2114466Open DOISearch in Google Scholar
Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, et al. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021. Vaccine. 2022;40(24):3389–94. doi: 10.1016/j.vaccine.2022.04.031MoroPLOlsonCKClarkEMarquezPStridPEllingtonSPost-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021Vaccine2022402433899410.1016/j.vaccine.2022.04.031Open DOISearch in Google Scholar
Yang YJ, Murphy EA, Singh S, Sukhu AC, Wolfe I, Adurty S, et al. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Obstet Gynecol. 2022;139(3):373–80. doi: 10.1097/AOG.0000000000004693YangYJMurphyEASinghSSukhuACWolfeIAdurtySAssociation of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at DeliveryObstet Gynecol202213933738010.1097/AOG.0000000000004693Open DOISearch in Google Scholar